Although, to the best of our knowledge, a direct evaluation of ECM changes with VEGF overexpression has not been performed, changes in the tumor ECM observed with anti-VEGF treatments provide useful insights in understanding the changes observed. The gene discussed is VEGFA; the disease is neoplasm.